21 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Initiative for Chronic ... LAMA: long-acting ... muscarinic antagonist; LABA ... #Management #Pulmonary ... #LAMA #LABA #ICS
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
pulmonary disease ... and exacerbation risk ... #COPD #Treatment ... #Pulmonary #LABA ... #LAMA #SABA #SAMA
Chronic Obstructive Pulmonary Disease (COPD)
 • COPD Definition
 • Role of PFTs
 • COPD Classification and
Pulmonary Disease ... post-bronchodilator FEV1 ... #Disease #COPD ... #diagnosis #management ... #GOLD2022 #treatment
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
to respiratory risk ... corticosteroids; LABA ... long-acting β2-agonist; LAMA ... #Diagnosis #Management ... Differences #Algorithm #Treatment
Multifocal Atrial Tachycardia (MAT)
• At least 3 different P wave morphologies: 
• Rate 100-180
• Irregular 
Etiology
• Secondary to chronic ... lung disease (COPD ... • Hypoxia • Pulmonary ... • Oxygen • Treatment ... MAT #Cardiology #Diagnosis
Hemophilia - Diagnosis and Management
Diagnosis:
 • Consistent bleeding history (unless screening for disease in family members
and Management ... Chronic Management ... Avoid meds that ... ↑ bleeding risk ... #Management #treatment
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Chronic Thromboembolic ... Bypass Other Treatment ... have inoperable disease ... pro-BNP levels • Risk ... #management
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... pneumonia • DM risk ... pneumonia • Chronic ... Lung #Abscess #pulmonary ... #treatment #diagnosis
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... • Silicosis • Chronic ... malignancy, and chronic ... Inhibitor: • Risk ... #Management #Treatment
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... days before Pulmonary ... Determine if any labs ... medical and surgical management ... stratification #diagnosis